{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:42:34Z","timestamp":1793727754934,"version":"4.6.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T00:00:00Z","timestamp":1651536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T00:00:00Z","timestamp":1651536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Acute lymphoblastic leukemia (ALL) is the most common malignant hematological diseases in children. An immunosuppressive microenvironment, particularly regulatory T cell (Treg) infiltration, has been documented to be highly associated with childhood ALL. This present study, based on genetic factors, was aimed at investigating the mutations potentially involved in the immunosuppressive microenvironment in childhood ALL. After whole-exome sequencing was used on DNA extracted from the T cells of ALL bone marrow samples, we found the FOXC1 H446HG induced a increased Treg while decreased cytotoxic T lymphocyte (CTL) in bone marrow. The mutation of FOXC1 in T cell promoted the proliferation of leukemia cells in vitro and in vivo. CpG islands formed by insertion mutation led to an abnormal increase in exon methylation and were associated with the suppression of FOXC1. Decreased FOXC1 attenuated the transcription of HDAC1, thus resulting in the activation of KLF10 through increasing H3K27 acetylation in the promoter region. In conclusion, the de novo insertion mutation in FOXC1 induced suppression of FOXC1, thereby promoting a Treg\/CTL shift in the ALL immune microenvironment. The FOXC1 H446HG mutation might be a potential therapeutic target for ALL in the future.<\/jats:p>","DOI":"10.1038\/s41419-022-04873-y","type":"journal-article","created":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T17:03:28Z","timestamp":1651597408000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Somatic FOXC1 insertion mutation remodels the immune microenvironment and promotes the progression of childhood acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"13","author":[{"given":"Yaping","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4299-6611","authenticated-orcid":false,"given":"Yuting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1081-6471","authenticated-orcid":false,"given":"Yongjun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,3]]},"reference":[{"key":"4873_CR1","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1001\/jamaoncol.2019.5868","volume":"6","author":"S Shen","year":"2020","unstructured":"Shen S, Chen X, Cai J, Yu J, Gao J, Hu S, et al. Effect of Dasatinib vs Imatinib in the treatment of pediatric philadelphia chromosome-positive acute lymphoblastic leukemia: A randomized clinical trial. JAMA Oncol. 2020;6:358\u201366.","journal-title":"JAMA Oncol"},{"key":"4873_CR2","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.3324\/haematol.2016.144345","volume":"101","author":"M Zaliova","year":"2016","unstructured":"Zaliova M, Moorman AV, Cazzaniga G, Stanulla M, Harvey RC, Roberts KG, et al. Characterization of leukemias with ETV6-ABL1 fusion. Haematologica. 2016;101:1082\u201393.","journal-title":"Haematologica"},{"key":"4873_CR3","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1111\/bjh.15129","volume":"180","author":"A Gutierrez","year":"2018","unstructured":"Gutierrez A, Kentsis A. Acute myeloid\/T-lymphoblastic leukaemia (AMTL): A distinct category of acute leukaemias with common pathogenesis in need of improved therapy. Br J Haematol. 2018;180:919\u201324.","journal-title":"Br J Haematol"},{"key":"4873_CR4","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/bjh.16441","volume":"189","author":"T Uden","year":"2020","unstructured":"Uden T, Bertaina A, Abrahamsson J, Ansari M, Balduzzi A, Bourquin JP, et al. Outcome of children relapsing after first allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: a retrospective I-BFM analysis of 333 children. Br J Haematol. 2020;189:745\u201350.","journal-title":"Br J Haematol"},{"key":"4873_CR5","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1182\/blood.2021011694","volume":"138","author":"JE Rubnitz","year":"2021","unstructured":"Rubnitz JE, Kaspers GJL. How I treat pediatric acute myeloid leukemia. Blood. 2021;138:1009\u201318.","journal-title":"Blood"},{"key":"4873_CR6","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1097\/MPH.0000000000002204","volume":"44","author":"MI Castellanos","year":"2021","unstructured":"Castellanos MI, Dongarwar D, Wanser R, Caceres I, Park C, Rodriguez J, et al. In-hospital mortality and racial disparity in children and adolescents with acute myeloid leukemia: A population-based study. J Pediatric Hematol\/Oncol. 2021;44:e114\u2013e122.","journal-title":"J Pediatric Hematol\/Oncol"},{"key":"4873_CR7","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/bjh.17494","volume":"194","author":"MB Michalowski","year":"2021","unstructured":"Michalowski MB, Cecconello DK, Lins MM, Carvalho M, Silva KAS, Cristofani L, et al. Influence of different asparaginase formulations in the prognosis of children with acute lymphocytic leukaemia in Brazil: A multicentre, retrospective controlled study. Br J Haematol. 2021;194:168\u201373.","journal-title":"Br J Haematol"},{"key":"4873_CR8","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1182\/bloodadvances.2021004424","volume":"5","author":"AJ Kaeding","year":"2021","unstructured":"Kaeding AJ, Barwe SP, Gopalakrishnapillai A, Ries RE, Alonzo TA, Gerbing RB, et al. Mesothelin is a novel cell surface disease marker and potential therapeutic target in acute myeloid leukemia. Blood Adv. 2021;5:2350\u201361.","journal-title":"Blood Adv"},{"key":"4873_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41577-021-00563-6","volume":"22","author":"X Zhao","year":"2021","unstructured":"Zhao X, Shan Q, Xue HH. TCF1 in T cell immunity: A broadened frontier. Nat Rev Immunol. 2021;22:147\u201357.","journal-title":"Nat Rev Immunol"},{"key":"4873_CR10","doi-asserted-by":"publisher","first-page":"5873","DOI":"10.4049\/jimmunol.0804074","volume":"182","author":"JB Jacob","year":"2009","unstructured":"Jacob JB, Kong YC, Nalbantoglu I, Snower DP, Wei WZ. Tumor regression following DNA vaccination and regulatory T cell depletion in neu transgenic mice leads to an increased risk for autoimmunity. J Immunol. 2009;182:5873\u201381.","journal-title":"J Immunol"},{"key":"4873_CR11","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.1158\/1078-0432.CCR-21-1589","volume":"27","author":"CS Zent","year":"2021","unstructured":"Zent CS. Ibrutinib restores tumor specific adaptive immunity in chronic lymphocytic leukemia. Clin Cancer Res: An Official J American Assoc Cancer Res. 2021;27:4465\u20137.","journal-title":"Clin Cancer Res: An Official J American Assoc Cancer Res"},{"key":"4873_CR12","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1001\/jama.2021.0987","volume":"325","author":"F Locatelli","year":"2021","unstructured":"Locatelli F, Zugmaier G, Rizzari C, Morris JD, Gruhn B, Klingebiel T, et al. Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial. Jama. 2021;325:843\u201354.","journal-title":"Jama"},{"key":"4873_CR13","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.critrevonc.2016.04.020","volume":"103","author":"R Austin","year":"2016","unstructured":"Austin R, Smyth MJ, Lane SW. Harnessing the immune system in acute myeloid leukaemia. Crit Rev Oncol\/Hematol. 2016;103:62\u201377.","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"4873_CR14","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1182\/blood.2020009871","volume":"138","author":"C Duault","year":"2021","unstructured":"Duault C, Kumar A, Taghi Khani A, Lee SJ, Yang L, Huang M, et al. Activated natural killer cells predict poor clinical prognosis in high-risk B- and T- cell acute lymphoblastic leukemia. Blood. 2021;138:1465\u201380.","journal-title":"Blood"},{"key":"4873_CR15","doi-asserted-by":"publisher","first-page":"663406","DOI":"10.3389\/fonc.2021.663406","volume":"11","author":"R Radpour","year":"2021","unstructured":"Radpour R, Stucki M, Riether C, Ochsenbein AF. Epigenetic silencing of immune-checkpoint receptors in bone marrow- infiltrating T cells in acute myeloid leukemia. Front Oncol. 2021;11:663406.","journal-title":"Front Oncol"},{"key":"4873_CR16","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1182\/blood.2019000553","volume":"138","author":"AP Silva","year":"2021","unstructured":"Silva AP, Almeida ARM, Cachucho A, Neto JL, Demeyer S, Ramos de Matos M, et al. Overexpression of wild type IL-7Ralpha promotes T-cell acute lymphoblastic leukemia\/lymphoma. Blood. 2021;138:1040\u201352.","journal-title":"Blood"},{"key":"4873_CR17","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1182\/blood.2021010867","volume":"137","author":"L Penter","year":"2021","unstructured":"Penter L, Zhang Y, Savell A, Huang T, Cieri N, Thrash EM, et al. Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation. Blood. 2021;137:3212\u20137.","journal-title":"Blood"},{"key":"4873_CR18","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1038\/s41375-021-01253-x","volume":"35","author":"N Daver","year":"2021","unstructured":"Daver N, Alotaibi AS, Bucklein V, Subklewe M. T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments. Leukemia. 2021;35:1843\u201363.","journal-title":"Leukemia"},{"key":"4873_CR19","doi-asserted-by":"publisher","first-page":"645653","DOI":"10.3389\/fimmu.2021.645653","volume":"12","author":"Q Li","year":"2021","unstructured":"Li Q, Li X, Quan H, Wang Y, Qu G, Shen Z, et al. IL-10(\u2212\/\u2212) Enhances DCs Immunity Against Chlamydia psittaci Infection via OX40L\/NLRP3 and IDO\/Treg Pathways. Front Immunol. 2021;12:645653.","journal-title":"Front Immunol"},{"key":"4873_CR20","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/s41419-018-1078-8","volume":"9","author":"Y Wang","year":"2018","unstructured":"Wang Y, Yang X, Sun X, Rong L, Kang M, Wu P, et al. Bone marrow infiltrated Lnc-INSR induced suppressive immune microenvironment in pediatric acute lymphoblastic leukemia. Cell Death Dis. 2018;9:1043.","journal-title":"Cell Death Dis"},{"key":"4873_CR21","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.cell.2021.02.027","volume":"184","author":"P Gonzalez-Figueroa","year":"2021","unstructured":"Gonzalez-Figueroa P, Roco JA, Papa I, Nunez Villacis L, Stanley M, Linterman MA, et al. Follicular regulatory T cells produce neuritin to regulate B cells. Cell. 2021;184:1775\u201389.e1719.","journal-title":"Cell"},{"key":"4873_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2217\/imt-2019-0108","volume":"12","author":"X Zhang","year":"2020","unstructured":"Zhang X, Yang J, Zhang G, Song L, Su Y, Shi Y, et al. 5 years of clinical DC-CIK\/NK cells immunotherapy for acute myeloid leukemia - a summary. Immunotherapy. 2020;12:63\u201374.","journal-title":"Immunotherapy"},{"key":"4873_CR23","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.intimp.2016.12.007","volume":"43","author":"CM Wun","year":"2017","unstructured":"Wun CM, Piao Z, Hong KT, Choi JY, Hong CR, Park JD, et al. Effect of donor STAT4 polymorphism rs7574865 on clinical outcomes of pediatric acute leukemia patients after hematopoietic stem cell transplant. Int Immunopharmacol. 2017;43:62\u20139.","journal-title":"Int Immunopharmacol"},{"key":"4873_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.gene.2013.04.028","volume":"524","author":"Y Wang","year":"2013","unstructured":"Wang Y, Chen J, Li J, Deng J, Rui Y, Lu Q, et al. Association of three polymorphisms in ARID5B, IKZF1 and CEBPE with the risk of childhood acute lymphoblastic leukemia in a Chinese population. Gene. 2013;524:203\u20137.","journal-title":"Gene"},{"key":"4873_CR25","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1080\/10428190902803677","volume":"50","author":"M Jak","year":"2009","unstructured":"Jak M, Mous R, Remmerswaal EB, Spijker R, Jaspers A, Yague A, et al. Enhanced formation and survival of CD4+ CD25hi Foxp3+ T-cells in chronic lymphocytic leukemia. Leuk lymphoma. 2009;50:788\u2013801.","journal-title":"Leuk lymphoma"},{"key":"4873_CR26","doi-asserted-by":"publisher","first-page":"656817","DOI":"10.3389\/fimmu.2021.656817","volume":"12","author":"SA O\u2019Brien","year":"2021","unstructured":"O\u2019Brien SA, Zhu M, Zhang W. Spontaneous differentiation of T follicular helper cells in LATY136F mutant mice. Front Immunol. 2021;12:656817.","journal-title":"Front Immunol"},{"key":"4873_CR27","doi-asserted-by":"publisher","first-page":"10292","DOI":"10.1074\/jbc.M110266200","volume":"277","author":"FB Berry","year":"2002","unstructured":"Berry FB, Saleem RA, Walter MA. FOXC1 transcriptional regulation is mediated by N- and C-terminal activation domains and contains a phosphorylated transcriptional inhibitory domain. J Biol Chem. 2002;277:10292\u20137.","journal-title":"J Biol Chem"},{"key":"4873_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/srep13749","volume":"5","author":"Y Wang","year":"2015","unstructured":"Wang Y, Wu P, Lin R, Rong L, Xue Y, Fang Y. LncRNA NALT interaction with NOTCH1 promoted cell proliferation in pediatric T cell acute lymphoblastic leukemia. Sci Rep. 2015;5:13749.","journal-title":"Sci Rep"},{"key":"4873_CR29","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ccell.2015.07.017","volume":"28","author":"TD Somerville","year":"2015","unstructured":"Somerville TD, Wiseman DH, Spencer GJ, Huang X, Lynch JT, Leong HS, et al. Frequent derepression of the mesenchymal transcription factor gene FOXC1 in acute myeloid leukemia. Cancer cell. 2015;28:329\u201342.","journal-title":"Cancer cell"},{"key":"4873_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-021-01013-9","volume":"13","author":"TJ Zhang","year":"2021","unstructured":"Zhang TJ, Xu ZJ, Gu Y, Ma JC, Wen XM, Zhang W, et al. Identification and validation of obesity-related gene LEP methylation as a prognostic indicator in patients with acute myeloid leukemia. Clin Epigen. 2021;13:16.","journal-title":"Clin Epigen"},{"key":"4873_CR31","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"4873_CR32","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ni.2703","volume":"14","author":"TF Gajewski","year":"2013","unstructured":"Gajewski TF, Schreiber H, Fu YX. Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol. 2013;14:1014\u201322.","journal-title":"Nat Immunol"},{"key":"4873_CR33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","volume":"141","author":"BZ Qian","year":"2010","unstructured":"Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010;141:39\u201351.","journal-title":"Cell"},{"key":"4873_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrc1782","volume":"6","author":"KE de Visser","year":"2006","unstructured":"de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer. 2006;6:24\u201337.","journal-title":"Nat Rev Cancer"},{"key":"4873_CR35","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1172\/JCI89756","volume":"127","author":"M Long","year":"2017","unstructured":"Long M, Beckwith K, Do P, Mundy BL, Gordon A, Lehman AM, et al. Ibrutinib treatment improves T cell number and function in CLL patients. J Clin Investig. 2017;127:3052\u201364.","journal-title":"J Clin Investig"},{"key":"4873_CR36","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/j.1349-7006.2003.tb01377.x","volume":"94","author":"K Chamoto","year":"2003","unstructured":"Chamoto K, Kosaka A, Tsuji T, Matsuzaki J, Sato T, Takeshima T, et al. Critical role of the Th1\/Tc1 circuit for the generation of tumor-specific CTL during tumor eradication in vivo by Th1-cell therapy. Cancer Sci. 2003;94:924\u20138.","journal-title":"Cancer Sci"},{"key":"4873_CR37","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1179\/1607845415Y.0000000025","volume":"20","author":"SZ Idris","year":"2015","unstructured":"Idris SZ, Hassan N, Lee LJ, Md Noor S, Osman R, Abdul-Jalil M, et al. Increased regulatory T cells in acute lymphoblastic leukemia patients. Hematology. 2015;20:523\u20139.","journal-title":"Hematology"},{"key":"4873_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-00773-y","volume":"12","author":"CC Sun","year":"2020","unstructured":"Sun CC, Zhu W, Li SJ, Hu W, Zhang J, Zhuo Y, et al. FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1alpha pathway. Genome Med. 2020;12:77.","journal-title":"Genome Med"},{"key":"4873_CR39","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1053\/j.gastro.2015.05.058","volume":"149","author":"W Huang","year":"2015","unstructured":"Huang W, Chen Z, Zhang L, Tian D, Wang D, Fan D, et al. Interleukin-8 Induces Expression of FOXC1 to Promote Transactivation of CXCR1 and CCL2 in Hepatocellular Carcinoma Cell Lines and Formation of Metastases in Mice. Gastroenterology. 2015;149:1053\u201367. e1014","journal-title":"Gastroenterology"},{"key":"4873_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-60480-x","volume":"10","author":"C Ward","year":"2020","unstructured":"Ward C, Cauchy P, Garcia P, Frampton J, Esteban MA, Volpe G. High WBP5 expression correlates with elevation of HOX genes levels and is associated with inferior survival in patients with acute myeloid leukaemia. Sci Rep. 2020;10:3505.","journal-title":"Sci Rep"},{"key":"4873_CR41","doi-asserted-by":"publisher","first-page":"e0167392","DOI":"10.1371\/journal.pone.0167392","volume":"11","author":"L Bin","year":"2016","unstructured":"Bin L, Deng L, Yang H, Zhu L, Wang X, Edwards MG, et al. Forkhead Box C1 regulates human primary keratinocyte terminal differentiation. PloS One. 2016;11:e0167392.","journal-title":"PloS One"},{"key":"4873_CR42","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1152\/physrev.00058.2009","volume":"90","author":"BB McConnell","year":"2010","unstructured":"McConnell BB, Yang VW. Mammalian Kruppel-like factors in health and diseases. Physiological Rev. 2010;90:1337\u201381.","journal-title":"Physiological Rev"},{"key":"4873_CR43","doi-asserted-by":"publisher","first-page":"24914","DOI":"10.1074\/jbc.M109.000059","volume":"284","author":"Z Cao","year":"2009","unstructured":"Cao Z, Wara AK, Icli B, Sun X, Packard RR, Esen F, et al. Kruppel-like factor KLF10 targets transforming growth factor-beta1 to regulate CD4(+)CD25(\u2212) T cells and T regulatory cells. J Biol Chem. 2009;284:24914\u201324.","journal-title":"J Biol Chem"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04873-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04873-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04873-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T14:48:02Z","timestamp":1669301282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04873-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,3]]},"references-count":43,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["4873"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-04873-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,3]]},"assertion":[{"value":"5 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Nanjing Medical University. Informed written consent was obtained from all subjects prior to the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"431"}}